Farallon Capital Management LLC

Search
⚲

Farallon Capital Management LLC ✚
CRD #	107322
SEC #	801-51763
CIK #	0000909661
AUM	52.08 B (2026-03-30)
Employees	355 (36% Investors, 0% Brokers)
Fees
Minimum
Phone	415-421-2132
Address	One Maritime Plaza San Francisco, CA 94111
Source	[IAPD] [EDGAR] [Website] [LinkedIn]

Total AUM ($B) Copy

In the News
Tue, 30 Jun 2026	Farallon Capital Management LLC Increases Stake in Centessa Phar — GuruFocus
Wed, 24 Jun 2026	Farallon Capital Management Discloses Investment in Centessa with 6.1% Stake — TradingView

Sector	Form 13F Holdings	Value ($B)
	Revolution Medicines Inc	1.3
	Amazon Com Inc	0.9
	Microsoft Corp	0.9
	Aon Corp	0.8
	Bridgebio Pharma Inc	0.7
	Protagonist Therapeutics Inc	0.7
	Natera Inc	0.6
	Exelixis Inc	0.6
	Broadcom Inc	0.6
	UnitedHealth Group Inc	0.5
View All

Holdings by Sector ($B)

Type	Form D Funds	Date	Sold	AUM
HF	Farallon Special Situations Master Fund III Non-US LP	[2024-06-10]		964.6 M
	Filed 2025-05-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Special Situations Master Fund III US LP	[2024-06-10]		217.4 M
	Filed 2025-05-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Special Situations Master X-VII LP	2023-03-29		268.5 M
HF	Farallon Co-Investment Master Fund LP	[2022-08-04]	0.1 M	49.8 M
	Filed 2025-05-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Real Estate Institutional Partners IV LP	[2022-08-04]		460.7 M
	Filed 2022-07-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Real Estate Partners IV LP	[2022-08-04]		200.9 M
	Filed 2022-07-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Special Investment Institutional Partners IV LP	[2022-02-14]	104.7 M	100.0 M
	Filed 2021-12-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
HF	Farallon Special Situations Master Credit IX LP	2022-02-14		259.6 M
HF	Farallon Healthcare Partners Master LP	[2021-08-03]	510.5 M	4,503.8 M
	Filed 2025-07-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Capital F5 CC LP	2021-03-30		295.4 M
HF	Farallon Special Situations Master Fund II LP	2021-02-08		1,248.5 M
HF	Farallon Special Investment Partners III LP	2020-05-11		89.7 M
HF	Farallon Special Situations Octave LP	2020-05-11		734.2 M
HF	Farallon Overflow Master Fund II LP	2019-11-14		4.0 M
HF	Farallon Special Situations Master VII LP	2019-11-14		404.2 M
HF	Farallon Real Estate Institutional Partners III LP	[2019-07-29]	137.6 M	233.8 M
	Filed 2020-01-24 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Real Estate Partners III LP	[2019-07-29]	82.4 M	76.4 M
	Filed 2020-01-24 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Capital Institutional Partners VI LP	2019-03-29		670.7 M
HF	Farallon Special Situations Master Fund LP	[2018-11-06]	332.0 M	191.6 M
	Filed 2018-10-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Four Crossings Institutional Partners V LP	2017-03-28		1,387.9 M
HF	Farallon Asia Special Situations Master III LP	[2016-07-07]	342.0 M	68.6 M
	Filed 2016-07-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
HF	Farallon Capital F5 Investors II LP	[2016-03-24]	237.1 M	304.3 M
	Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Capital F5 Investors I LP	[2016-03-24]	1,123.6 M	935.6 M
	Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Capital F5 Investors International LP	2016-03-24		147.5 M
HF	Farallon Capital Offshore Investors Inc - Investing Classes	2016-03-24		1,841.1 M
HF	Farallon Equity Partners Master LP	[2016-03-24]	949.7 M	7,204.8 M
	Filed 2026-02-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Real Estate Institutional Partners II LP	[2016-03-24]	189.0 M	41.9 M
	Filed 2016-02-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Real Estate Partners II LP	[2016-03-24]	33.6 M	9.8 M
	Filed 2016-02-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	FCOI II Currency Class Fund Ltd	2016-03-24		1,737.3 M
HF	FCOI II Holdings LP	2016-03-24		6,346.9 M
HF	Farallon Capital F5 Master II LP	[2015-10-13]	1,123.6 M
	Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Capital F5 Master I LP	[2015-10-13]	1,123.6 M	1,860.1 M
	Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Overflow Fund LP	2015-06-05		197.3 M
HF	Farallon European Private Credit Master LP	[2014-02-20]	102.2 M	11.0 M
	Filed 2014-01-07 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF	Farallon Real Estate Institutional Partners LP	[2013-11-14]	186.1 M	10.1 M
	Filed 2014-08-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Real Estate Partners LP	[2013-11-14]	59.1 M	4.1 M
	Filed 2014-08-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF	Farallon Capital AA Investors LP	2013-05-02		69.0 M
HF	Farallon Special Situation Partners VI LP	[2013-02-20]	40.0 M	94.0 M
	Filed 2013-03-18 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF	Farallon Special Situation Partners IV LP	2012-08-07		25.5 M
HF	Farallon Special Situation Partners Master III LP	2012-08-07		5.2 M
HF	Farallon Special Situation Partners V LP	2012-08-07		2.9 M
HF	Farallon Asia Special Situations Master II LP	[2012-03-30]	319.5 M	20.9 M
	Filed 2014-03-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF	Farallon Asia Special Situations Master LP	[2012-03-30]	237.8 M	7.9 M
	Filed 2014-03-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF	Farallon Capital AM Investors LP	[2012-03-30]	130.5 M	841.4 M
	Filed 2026-03-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Capital Institutional Partners 25 LP	2012-03-30		3.9 M
HF	Farallon Capital Institutional Partners III LP	2012-03-30		1,073.5 M
HF	Farallon Capital Institutional Partners II LP	2012-03-30		2,150.8 M
HF	Farallon Capital Institutional Partners LP	2012-03-30		7,429.8 M
HF	Farallon Capital Offshore Investors II LP	2012-03-30		13.54 B
HF	Farallon Capital Offshore Investors Inc - Classes A/B/E	2012-03-30		21.7 M
HF	Farallon Capital Partners LP	2012-03-30		6,029.4 M
HF	Farallon Credit Sidecar International LP	[2012-03-30]		1.3 M
HF	Farallon Credit Sidecar Master II LP	[2012-03-30]		19.9 M
HF	Farallon Credit Sidecar Master I LP	[2012-03-30]		10.8 M
HF	Farallon Credit Sidecar Partners II LP	[2012-03-30]		3.0 M
HF	Farallon Credit Sidecar Partners I LP	[2012-03-30]		6.2 M
HF	Farallon Investment Holdings LP	[2012-03-30]	51.5 M	39.8 M
	Filed 2026-03-09 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Realty Partners LP	2012-03-30		0.4 M
HF	Farallon Special Investment Partners II LP	[2012-03-30]	70.2 M	6.5 M
	Filed 2013-03-18 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Special Investment Partners LP	[2012-03-30]	220.5 M	7.0 M
	Filed 2013-03-18 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Farallon Special Situation Partners III LP	2012-03-30		184.2 M
HF	Farallon Special Situation Partners II LP	2012-03-30		0.9 M
HF	Farallon Special Situation Partners LP	2012-03-30		0.1 M
HF	Noonday Capital Partners LLC	2012-03-30		0.5 M
HF	Noonday Offshore Inc	2012-03-30		303.1 M
HF	Noonday Special Situation Partners LP	2012-03-30		56.9 M
HF	RR Capital Partners LP	2012-03-30		2.2 M
HF	Sidecar Partners LP	2012-03-30		11.1 M
HF	Tinicum Partners LP	2012-03-30		2.6 M

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	66	52.0
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.1
Total	67	52.1
By Discretionary
Discretionary	67	52.1
Non-Discretionary	0	0.0
Total	67	52.1
By Non-United States Persons
Non-United States Persons		21.9
United States Persons		30.1
Total	67	52.1

Limited Partners	2011 - 2026
New Jersey Division of Investment
Virginia Retirement System

Form D Directors	Role	# Filings	# Firms
Grant Jackson	Director	175	39
Martin Lang	Director	161	31
Russell Burt	Director	113	29
David Kim	Executive Officer	88	7
Michael Fisch	Executive Officer	42	5
Michael Linn	Executive Officer	41	4
Daniel Hirsch	Executive Officer	29	3
Cameron Hillyer	Executive Officer	27	3
Thomas Steyer	Executive Officer	21	3
Jason Moment	Executive Officer	13	3
View All

EDGAR Form	CIK	2011 - 2026
13F-HR	[0000909661]
3	[0000909661]
4	[0000909661]
SC 13D	[0000909661]
SC 13G	[0000909661]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Farallon Capital Management LLC	Centessa Pharmaceuticals PLC	[2026-06-24]
Farallon Capital Management LLC	Amyris Inc	[2022-02-24]
Farallon Capital Management LLC	Swiftmerge Acquisition Corp	[2021-12-27]
Farallon Capital Management LLC	Khosla Ventures Acquisition Co III	[2021-03-31]
Farallon Capital Management LLC	Longboard Pharmaceuticals Inc	[2021-03-25]
Farallon Capital Management LLC	Amyris Inc	[2020-08-20]
Farallon Capital Management LLC	Broadmark Realty Capital Inc	[2019-11-22]
Farallon Capital Management LLC	Enanta Pharmaceuticals Inc	[2019-09-27]
Farallon Capital Management LLC	Dermtech Inc	[2019-09-09]
Farallon Capital Management LLC	Dermtech Inc	[2019-09-06]
View All

Firm Profile (Form ADV)
Discretionary AUM	$28.9B
Clients	1 (63 non-US)
Serves	Institutional
Fund Types	Hedge Fund, Private Equity
LEI	87DR6WT2MK1KMGUC7161

Related People Network
47 people file Form D offerings alongside this firm's people.

Form 3/4/5 Subject	2011 - 2026
Fisch Michael B
Fried Richard B
Marblegate Acquisition Corp
Giauque Nicolas
Linn Michael G
Dreyfuss Philip D
Gehani Varun N
Grassland Investors LLC
Patel Rajiv A
Kim David T
View All

Insider Transaction (Form 3/4/5)	Date	Action	Shares	Price	Value ($)
Generation Bio Co GBIO Common Stock	2020-06-16	Conversion	1,518,819
Generation Bio Co GBIO Common Stock	2020-06-16	Buy	400,000	$19.00	7,600,000
Generation Bio Co GBIO Series C Preferred Stock · derivative	2020-06-16	Conversion	2,682,691
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	249,462	$6.72	1,676,385
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	833,845	$6.72	5,603,438
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	915,583	$6.72	6,152,718
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	899,268	$6.72	6,043,081
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	209,577	$6.72	1,408,357
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	2,067,651	$6.72	13,894,615
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	122,006	$6.72	819,880
Nexvet Biopharma PLC NVET Ordinary Shares	2017-07-31	Tender	2,648,696	$6.72	17,799,237
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	3,007	$3.36	10,104
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	3,303	$3.36	11,098
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	9,554	$3.36	32,101
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	440	$3.36	1,478
Nexvet Biopharma PLC NVET Ordinary Share	2016-02-26	Buy	3,244	$3.36	10,900
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	756	$3.36	2,540
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	7,458	$3.36	25,059
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-26	Buy	900	$3.36	3,024
Nexvet Biopharma PLC NVET Ordinary Shares	2016-02-25	Buy	65,694	$3.18	208,907
showing 20 of 163 most recent transactions

Comparable Firms	State	AUM
Marshall Wace North America LP ✚	NY	58.87 B
Blackstone Private Credit Strategies LLC ✚	NY	57.92 B
TA Associates Management LP ✚	MA	55.07 B
Veritas Capital Fund Management LLC ✚	NY	53.81 B
Blackstone Liquid Credit Advisors I LLC ✚	NY	51.63 B
Crescent Capital Group LP ✚	CA	49.71 B
ICG Investments Inc ✚	NY	49.69 B
Macquarie Infrastructure Partners Inc ✚	NY	48.84 B
Antares Capital Advisers LLC ✚	IL	47.39 B
Silver Point Capital LP ✚	CT	46.23 B

Farallon Capital Management LLC

Assets, Funds, Holdings